webinar register page

Neurological Associations of COVID-19: Neurological Associations of COVID-19: Pooling global data on NeuroCOVID
The COVID-19 pandemic, caused by SARS-CoV-2, is of a scale not seen since the 1918 influenza pandemic. Although the predominant clinical presentation is with respiratory disease, neurological manifestations frequent. In this episode, it is all about pooling global data on NeuroCOVID. Leads of the European Academy of Neurology (EAN) Neurocovid Registry and the Global Consortium Study (GCS) of Neurological Dysfunction in COVID-19 will present their registries. We will also present first data from the COVID-Neuro Network’s global meta-analysis of individual patient data on neurological associations of COVID-19. We will also have a brief literature digest from @Neuropsychcovid.

Dr Sherry H-Y. Chou, University of Pittsburgh School of Medicine, United States of America
Title: The GCS-NeuroCOVID Consortium - Design, rationale, and global harmonization

Prof Ettore Beghi, Mario Negri Institute for Pharmacological Research, Italy
Title: The EAN Neurocovid Registry: Background, Data collection and Perspectives

Dr Suzannah Lant, University of Liverpool, United Kingdom
Title: Neurological associations of COVID-19 – a global meta-analysis of individual patient data

Matt Butler, South London and Maudsley NHS Foundation Trust & King’s College London, United Kingdom
Title: COVID-Neuro Highlights from JNNP Blog:

Chair: Professor Tom Solomon
Chair of Neurological Science, University of Liverpool, Director of the National Institute for Health Research (NIHR) Health Protection Research Unit in Emerging and Zoonotic Infections

Brain Infections Global: An NIHR Global Health Research Group on Improving the Management of Acute Brain Infections

Visit: https://braininfectionsglobal.tghn.org/

The Global Health Network's privacy policy: https://braininfectionsglobal.tghn.org/terms/privacy/

Dec 11, 2020 01:00 PM in London

Webinar logo
* Required information

By registering, I agree to the Privacy Statement and Terms of Service.



Prof Ettore Beghi
@Mario Negri Institute for Pharmacological Research, Italy
Prof Ettore Beghi is the Head of the Laboratory of Neurological Disorders at the Mario Negri Institute for Pharmacological Research, Milan, Italy and Professor of Neuroepidemiology at the University of Milan, Italy. His research interests are epilepsy, peripheral neuropathy, amyotrophic lateral sclerosis, myasthenia gravis, Parkinson’s disease, headache and stroke.
Dr Sherry H-Y. Chou
@University of Pittsburgh School of Medicine, United States of America
Dr. Sherry Chou is a physician-scientist with expertise in clinical neurology, neurocritical care and vascular neurology and award-winning mentor. Dr. Chou’s research program focuses on the role of inflammation and immune response in vascular brain injuries and biomarker discovery. Dr. Chou founded and leads the large Global Consortium Study on Neurological Dysfunction in COVID 19 (GCS-NeuroCOVID) and serves as an invited member to the World Health Organization forum on neurological impacts of COVID 19. Nationally, Dr. Chou serves on the Board of Directors and as research subcommittee chair of the Neurocritical Care Society.
Dr Suzannah Lant
@University of Liverpool, United Kingdom
Dr Suzannah Lant has a background in clinical and laboratory studies, investigating neurological disease. She has co-ordinated a multicentre case-control study examining the association between infection with arthropod-borne viruses and the development of neurological disease in Brazil. Currently, she is co-ordinating a meta-analysis of individual patient data from studies into COVID-19 and neurological disease, which is being conducted with over 100 international collaborators.